Singapore markets closed

VitaSpring Biomedical Co. Ltd. (VSBC)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
15.000.00 (0.00%)
As of 02:03PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 3.30B
Enterprise value 3.30B
Trailing P/E 3.53k
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)664.53
Price/book (mrq)1.97k
Enterprise value/revenue 663.71
Enterprise value/EBITDA 2.77k

Trading information

Stock price history

Beta (5Y monthly) 1.17
52-week change 36.67%
S&P500 52-week change 324.19%
52-week high 316.00
52-week low 313.10
50-day moving average 316.00
200-day moving average 316.00

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5206.52M
Implied shares outstanding 6206.52M
Float 8N/A
% held by insiders 158.77%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 25:1
Last split date 329 Jun 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Jan 2022
Most-recent quarter (mrq)31 Oct 2022

Profitability

Profit margin 18.79%
Operating margin (ttm)23.62%

Management effectiveness

Return on assets (ttm)40.98%
Return on equity (ttm)84.16%

Income statement

Revenue (ttm)4.98M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA 1.19M
Net income avi to common (ttm)935.61k
Diluted EPS (ttm)0.00
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)24.05k
Total cash per share (mrq)0
Total debt (mrq)329.63k
Total debt/equity (mrq)19.61%
Current ratio (mrq)4.33
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-240.01k
Levered free cash flow (ttm)-481.1k